Financial Statements — XXI
Balance Sheet
(in billions USD)| Metric | Q2
2026 | Q1
2026 | Q3
2025 |
|---|
| Cash & Equivalents | 0.11 | 0.11 | 0.00 |
| Total Current Assets | 0.11 | 0.12 | -- |
| Total Assets | 2.66 | 3.07 | -- |
| Total Current Liabilities | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 0.49 | 0.49 | 0.00 |
| Retained Earnings | (1.54) | (1.12) | -0.00 |
| Total Stockholder Equity | 2.18 | 2.59 | -0.00 |
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2026 | Q1
2026 | Q3
2025 |
|---|
| Pretax Income | (413.54) | (859.69) | -- |
| Net Income | (413.54) | (859.69) | (0.06) |
| Basic EPS | -- | -- | (57,798.00) |
| Diluted EPS | -- | -- | (57,798.00) |
Cash Flow Statement
(in millions USD)| Metric | Q2
2026 | Q1
2026 |
|---|
| Operating Cash Flow | (7.93) | (3.65) |
| Financing Cash Flow | 0.20 | -- |
